1. Strengthening pharmacovigilance to reduce adverse effects of medicines. MEMO/08/782. Brussels, December – November (2008). Accessed 27 Apr 2023. http://europa.eu/rapid/press-release_MEMO-08-782_en.htm
2. Commission of the European Communities. Commission staff working document Annex 2 of the Report on the impact assessment of strengthening and rationalizing EU Pharmacovigi-lance. 2008. Brussels, 10.12.2008, SEC (2008) 2671 C6–0514–0515/08
3. Official journal of the European union, council conclusions on personalised medicine for patients, (2015/C 421/03)4
4. Guchelaar, H.-J.: Pharmacogenomics, a novel section in the European journal of human genetics. Eur. J. Hum. Genet. 26, 1399–1400 (2018). https://doi.org/10.1038/s41431-018-0205-4
5. Schärfe, C.P.I., et al.: Genetic variation in human drug-related genes. Genome Med. 9, 117 (2017). https://doi.org/10.1186/s13073-017-0502-5